FDA
-
-
-
-
-
-
-
Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System
-
-
-
-
-
-
-
Artivion receives FDA approval for NEXUS aortic arch treatment system
-
-
-
-
-
-
-
Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting
-
-
-
-
-
-
-
Artivion Inc. (AORT) PT Raised to $40 at Oppenheimer
-
-
-
-
-
-
-
Artivion Reports Fourth Quarter and Full Year 2024 Financial Results
-
-
-
-
-
-
-
JMP Securities Starts Artivion Inc. (AORT) at Market Outperform
-
-
-
-
-
-
-
Artivion Reports Fourth Quarter and Full Year 2023 Financial Results
-
326,488 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

